District Of Columbia 2023-2024 Regular Session

District Of Columbia Council Bill PR25-0497 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1
2	2
3	3
4	4
5	5	MURIEL BOWSER
6	6	MAYOR
7	7
8	8	October 26, 2023
9	9
10	10
11	11	The Honorable Phil Mendelson
12	12	Chairman
13	13	Council of the District of Columbia
14	14	John A. Wilson Building
15	15	1350 Pennsylvania Avenue, NW, Suite 504
16	16	Washington, DC 20004
17	17
18	18	Dear Chairman Mendelson:
19	19
20	20
21	21	In accordance with section 2 of the Confirmation Act of 1978, effective March 3, 1979 (D.C.
22	22	Law 2-142; D.C. Official Code § 1- 523.01) , and pursuant to section 3042 of the Fatality Review
23	23	Committee Amendment Act of 2018, effective October 30, 2018 (D.C. Law 22- 168; D.C.
24	24	Official Code § 5-1431.01), I am pleased to nominate the following individual :
25	25
26	26	Dr. Eric Li
27	27	Fernwood Road
28	28	Bethesda, MD 20817
29	29	for reappointment as a representative of a District hospital member of the Violence Fatality
30	30	Review Committee , for a term to end October 12, 2025.
31	31	Enclosed you will find biographical information detailing the experience of the above-mentioned
32	32	nominee, together with proposed resolutions to assist the Council during the confirmation process.
33	33	I would appreciate the Council’s earliest consideration of this nomination for confirmation. Please do not hesitate to contact me, or Steven Walker, Director, Mayor’s Office of Talent and Appointments, should the Council require additional information. Sincerely,
34	34	Muriel Bowser 1
35	35	2
36	36	3
37	37	4
38	38	5
39	39	6
40	40	7
41	41	8
42	42	9
43	43	10
44	44	11
45	45	12
46	46	at the request of the Mayor
47	47	A PROPOSED RESOLUTION
48	48	IN THE COUNCIL OF THE DISTRICT OF COLUMBIA
49	49	13 To confirm the reappointment of Dr. Eric Li to the Violence Fatality Review Committee.
50	50	14
51	51	15 RESOLVED, BY THE COUNCIL OF THE DISTRICT OF COLUMBIA, That this
52	52	16 resolution may be cited as the "Violence Fatality Review Committee Dr. Eric Li Confirmation
53	53	17 Resolution of 2023".
54	54	18
55	55	19 Sec. 2. The Council of the District of Columbia confirms the reappointment of:
56	56	20
57	57	21
58	58	22
59	59	23
60	60	24
61	61	Dr. Eric Li
62	62	Femwood Road
63	63	Bethesda, MD 20817
64	64	25 as a representative of a District hospital member of the Violence Fatality Review Committee,
65	65	26 established by section 3042 of the Fatality Review Committee Amendment Act of 2018,
66	66	27 effective October 30, 2018 (D.C. Law 22-168; D.C. Official Code§ 5-1431.01), for a term to
67	67	28 end October 12, 2025.
68	68	29 Sec. 3. The Council of the District of Columbia shall transmit a copy of this resolution,
69	69	30 upon its adoption, to the nominee and to the Office of the Mayor.
70	70	31 Sec. 4. This resolution shall take effect immediately. Eric Li, M.D.
71	71
72	72	Interim Chief Medical Officer
73	73	and
74	74	Chairman, Department of Pathology
75	75
76	76	United Medical Center
77	77	1310 Southern Ave, SE
78	78	Washington, DC 20032 E-mail: eli@united-medicalcenter.com
79	79
80	80	Professional Summary:
81	81	I am a leader, physician, and educator. I have worked and trained at some of United
82	82	States most prestigious universities.
83	83
84	84	Professional Interest:
85	85	Provide the highest level of quality service to medical center and University hospital.
86	86	Participate pathology service.
87	87
88	88	Professional Experience:
89	89	United Medical Center 2017 – 9/2019
90	90	Interim Chief Medical Officer
91	91	• Responsible for all hospital operations.
92	92	In 2017, I became Chief Medical Officer in United medical Center on interim basis . This
93	93	is most senior position. United medical Center belongs to Washington DC and one of
94	94	oldest public hospital in the country. I was responsible for managing the operation of the entire hospital. I served as a member of the hospital’s board of directors. Since assume
95	95	this position, we overcome paramount challenges. We are currently building a new
96	96	hospital together with George Washington University .
97	97	United Medical Center 2016 – Present
98	98	Chairman, Department of Pathology
99	99
100	100	• Responsible for Anatomical and Clinical Pathology services.
101	101
102	102	VA Hudson Valley Health Care System 2015 – 2016
103	103	Pathologist, Department of Pathology
104	104	• Anatomical and Clinical pathology services.
105	105
106	106	Columbia Memorial Hospital, Hudson, NY 2009 - 2015
107	107	Clifton Fine Hospital, New York
108	108	Director, Department of Pathology
109	109	• Responsible for Anatomical and Clinical Pathology services. Eric Y. Li, M.D.
110	110
111	111
112	112
113	113	Page 2
114	114
115	115	(Continued)
116	116	In 2009, I became the Director of the Pathology department at Columbia Memorial
117	117	Hospital. I was also responsible for managing the operation of the entire department as
118	118	well as overseeing departmental compliance and regulations. I served as a member of the
119	119	hospital’s medical executive committee.
120	120	Claxton-Hepburn Medical Center, Ogdensburg, NY 2003 - 2009
121	121	Clifton Fine Hospital, New York
122	122	Director, Department of Pathology
123	123	• Responsible for Anatomical and Clinical P athology services.
124	124	In 2003, I became the Director of the Pathology department at Claxton- Hepburn Medical
125	125	Center. Clinical pathology and manage ment of the laboratory were important parts of my
126	126	responsibility. I was responsible for managing the operation of the entire department as
127	127	well as overseeing departmental compliance and regulations. I served as a member of the
128	128	hospital’s medical executive committee.
129	129	New York University Medical Center, New York, NY 2002- 2003
130	130	Assistant Professor, Department of Pathology
131	131	• Studied cytology and OB/GYN pathology.
132	132	St. Johns Riverside Hospital at Yonkers, NY 2001- 2002
133	133	Director, Department of Pathology
134	134	• Responsible for Anatomical and Clinical Pathology services.
135	135
136	136	New York University Medical Center, New York, NY 2000- 2001
137	137	Assistant Professor, Department of Pathology
138	138	• Responsible for Anatomical Pathology services, teaching fellows, residents, medical
139	139	students and research.
140	140	During this period, I served as the attending physician at the New York University Medical Center. It was an academic setting that utilized a multiple discipline approach.
141	141	The hospital is famous for the complex cases it receives and the expertise among its
142	142	Pathologists. I was a key member of the surgical pathology team and was responsible
143	143	for the selection and recruiting of pathology fellowship candidates. I was engaged in
144	144	cancer research and maintained an American Cancer Society grant. I also teach medical
145	145	students. I have given lectures on Tuberculosis infection and was the Lab leader on
146	146	inflammatory pathology. Dartmouth-Hitchcock Medical Center/Weeks Hospital 1998-1999
147	147	Attending Pathologist, Department of Pathology
148	148	• Responsible for Anatomical and Clinical Pathology services.
149	149	• Chief Inspector, College of American Pathologists.
150	150
151	151	Dartmouth-Hitchcock Medical Center/VA Hospital, WRJ, VT 1997
152	152	• Responsible for Anatomical Pathology and overseeing departmental operation. Eric Y. Li, M.D.
153	153
154	154
155	155
156	156	Page 3
157	157
158	158	(Continued)
159	159	• Educate residents and worked as Lab leader on cardiovascular pathology.
160	160
161	161	Clinical and Postgraduate Training:
162	162	Johns Hopkins Hospital, Maryland, MD 1999-2000
163	163	Fellowship in Hepatic and Gastrointestinal Pathology
164	164
165	165	Dartmouth-Hitchcock Medical Center 1997-1998
166	166	Clinical Pathology Resident, Department of Pathology,
167	167
168	168	Dartmouth-Hitchcock Medical Center 1995-1996
169	169	Clinical Pathology Resident, Department of Pathology,
170	170
171	171	Yale-New Haven Hospital, CT 1993-1995
172	172	Anatomic Pathology Resident, Department of Pathology, Yale University, School of Medicine, CT 1992-1993
173	173	Post-doctoral associate, Department of Pathology
174	174	Yale University, School of Medicine, CT 1988-1992
175	175	Post-doctoral associate, Department of pharmacology
176	176	Peking Union Medical College 1986-1988 Lecturer, Department of pharmacology
177	177
178	178	Licensure and Certification
179	179	2016 Registered Physician, Board of Registration in Medicine, Washington D.C. 2000 Registered Physician, Board of Registration in Medicine, State of New York 1999 Registered Physician, Board of Registration in Medicine, State of Vermont 1998 Diplomat, American Board of Pathology (Anatomic Pathology) 1998 Diplomat, American Board of Pathology (Clinical Pathology) 1997 Registered Physician, Board of Registration in Medicine, State of New Hampshire
180	180	Education:
181	181	1983-1986 M.D., Peking Union Medical College, Chinese Academy of Medical
182	182	Sciences, Beijing, China
183	183	1978-1982 Bachelor of Medicine, Nanjing Railway Medical College, China
184	184
185	185
186	186
187	187	SELECT PUBLICATIONS
188	188	Eric Y. Li, M.D.
189	189
190	190
191	191
192	192	Page 4
193	193
194	194	(Continued)
195	195	Refereed Journal Publications, investigative science
196	196
197	197	1. Dianne Pulte, M.D.
198	198
199	199	, Eric Li, M.D.
200	200
201	201	, Bernard K. Crawford, M.D.
202	202
203	203	, Elliot Newman,
204	204	M.D.
205	205
206	206	, Alice Alexander, Ph.D.
207	207
208	208	, David C. Mustalish
209	209
210	210	, Daniel R. Jacobson, M.D.
211	211
212	212
213	213	Sentinel Lymph Node Mapping and Molecular Staging in Non-Small Cell Lung
214	214	Cancer. Cancer. 2005, vol. 104, n
215	215	o
216	216	7, pp. 1453-1461
217	217	2. Jianjun Wei, Luis Chiriboga, Herman Yee, Masashi Mizuguchi, Eric Li , Gurdip
218	218	S. Sidhu, and A. Brian West. Altered Cellular Distribution of Tuberin and Glucocorticoid Receptor in Sporadic Fundic Gland Polyps. Mod. Pathol. 2002 15: 862-869
219	219	3. Carole Hazan, Kate Melzer, Katherine S. Panageas, Eric Li, Hideko Kamino, Alfred Kopf, Carlos Cordon-Cardo, Iman Osman, David Polsky. Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma.
220	220	Cancer 95, 3: 634-640
221	221	4. H. Xiao, E. Li, Y. Makeyev, N. Dean, B. Vikram, W. A. Franklin Inhibition of Bcl-xL, an Anti-Apoptotic Protein, by Antisense Oligonucleotide
222	222	Potentiated g-radiation Induced Apoptosis in Human Adenocarcinoma of the Lung. Radiation Research, submitted.
223	223	5. E. Li, H. Xiao, B. Vikram, Differential Expression of Bcl-2 and Bcl-xL in
224	224	Human Small Cell Lung Cancer and Adenocarcinoma of the Lung. Submitted.
225	225	6. David B. Bregman, Lei Du, Eric Li, Stephen Ribose and Stephen L. Warren. Cytostellin distributes to nuclear regions enriched with splicing factors. Journal of
226	226	Cell Science 107, 387-396, 1994.
227	227	7. Eric Li, Lyndon Lewellen and Edward Moczydlowski. Biochemical and
228	228	Immunochemical comparison of Saxiphilin and transferrin, two structurally
229	229	related plasma proteins from Rana Catesbeiana. Molecular Pharmacology 44(4):
230	230	742-748, 1993.
231	231	8. Eric Li, and Edward Moczydlowski. Purification and partial sequencing of
232	232	Saxiphilin, a saxitoxin-binding protein from the bullfrog, reveal homology to
233	233	transferrin. Journal of Biological Chemistry, 266: 15481-15487, 1991.
234	234	9. Janice Mahar, Gergely L. Lukacs, Eric Li, Sherwood Hall and Edward
235	235	Moczydlowski. Pharmacological and biochemical properties of Saxiphilin, a
236	236	soluble saxitoxin-binding protein from the bullfrog (Rana Catesbeiana). Toxicon,
237	237	29: 53-71, 1991.
238	238
239	239	Symposium Proceedings
240	240	10. Eric Li, Helen Xiao and Bhadrasain Vikram. Differential expression of Bcl-2 and Bcl-xL in human small cell lung cancer (sclc) and adenocarcinoma of the lung
241	241	(ACL). United States and Canadian Academy of Pathology. Annual Meeting, Atlanta, Georgia, USA, 2001.
242	242	11. Eric Li, Helen Xiao and Bhadrasain Vikram. Bcl-xL, overexpressed in human
243	243	lung adenocarcinoma (acl), is an ideal target for antisense therapy. United States and Canadian Academy of Pathology. Annual Meeting, Atlanta, Georgia, USA, 2001. Accepted as platform presentation. Eric Y. Li, M.D.
244	244
245	245
246	246
247	247	Page 5
248	248
249	249	(Continued)
250	250	12. Eric Li and Anna Mae Diehl. Un-coupling Protein 2 expression in acute alcoholic
251	251	hepatitis. United States and Canadian Academy of Pathology. Annual Meeting, New Orleans, LA, USA, 2000
252	252	13. Frank Polito, Eric Li, Kiang- Teck Yeo. Clinical evaluation of the cornine 855
253	253	blood gas electrolyte co- oximeter system. AACC Meetings, Washington, DC.
254	254	USA, 1996
255	255	14. Eric Li, and Edward Moczydlowski. Purification and partial sequencing of Saxiphilin, a saxitoxin- binding protein from the bullfrog, reveal homology to
256	256	transferrin. 1990 Yale Department of Pharmacology annual research conference.
257	257
258	258	Executive Office of the Mayor - Office of Talent and Appointments
259	259	John A. Wilson Building \| 1350 Pennsylvania Avenue, Suite 600 \| Washington, DC 20004
260	260
261	261
262	262
263	263	Dr. Eric Li
264	264
265	265	Dr. Eric Li was brought on at United Medical Center as the Chairman
266	266	of the Department of pathology in 2016. In 2017, Dr. Eric Li became
267	267	Interim Chief Medical Officer at United M edical Center, one of the
268	268	oldest public hospital s in the country. While there, he was responsible
269	269	for managing the operations of the entire hospital, and has even served
270	270	as a member of the hospital’s B oard of Directors. Since assuming the
271	271	role as Interim Chief Medical Officer, he has helped the hospital
272	272	overcome paramount challenges. In September 2019 his time as
273	273	Interim Chief Medical Officer ended, and he continues to serve as the
274	274	Chairman of the hospital’s Pathology department.
275	275
276	276	Dr. Li has been studying medicine since 1978, appeared in several publications and conducted
277	277	several symposium proceedings. GOVERNMENT OF THE DISTRICT OF COLUMBIA
278	278	Executive Office of Mayor Muriel Bowser
279	279
280	280	Office of the General Counsel to the Mayor
281	281
282	282
283	283	______________________________________________________________________________
284	284	The John A. Wilson Building • 1350 Pennsylvania Avenue, NW • Suite 300 • Washington, D.C. 20004 • Office (202) 724 -7681
285	285
286	286	To: Tommy Wells, Steve Walker
287	287	From: Betsy Cavendish
288	288	Date: July 28, 2023
289	289	Subject: Legal sufficiency review of Resolutions nominating Charlayne Hayling- Williams,
290	290	Dr. Eric Li, Dr. Erin Hall, Helaina Roisman, Joseph Richardson, Juanita Price, Kenyatta Hazlewood, and Dr. Mallory Williams as members of the Violence
291	291	Fatality Review Committee
292	292	This is to Certify that this office has reviewed the above- referenced resolutions and
293	293	found them to be legally unobjectionable. If you have any questions in this regard, please do not
294	294	hesitate to call Vanessa Careiro, Deputy General Counsel, Executive Office of the Mayor, at 202-724-1303, or me at 202- 724-7681.
295	295
296	296
297	297	______________________________ Elizabeth A. (Betsy) Cavendish
298	298